DE69631930D1 - Stabilisiertes wässriges flüssiges Blutgerinnungsfaktor XIII-Präparat - Google Patents

Stabilisiertes wässriges flüssiges Blutgerinnungsfaktor XIII-Präparat

Info

Publication number
DE69631930D1
DE69631930D1 DE69631930T DE69631930T DE69631930D1 DE 69631930 D1 DE69631930 D1 DE 69631930D1 DE 69631930 T DE69631930 T DE 69631930T DE 69631930 T DE69631930 T DE 69631930T DE 69631930 D1 DE69631930 D1 DE 69631930D1
Authority
DE
Germany
Prior art keywords
aqueous liquid
coagulation factor
factor xiii
stabilized aqueous
liquid coagulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69631930T
Other languages
English (en)
Other versions
DE69631930T2 (de
Inventor
Naoko Kato
Shuji Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Publication of DE69631930D1 publication Critical patent/DE69631930D1/de
Application granted granted Critical
Publication of DE69631930T2 publication Critical patent/DE69631930T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DE69631930T 1995-06-05 1996-06-03 Stabilisiertes wässriges flüssiges Blutgerinnungsfaktor XIII-Präparat Expired - Lifetime DE69631930T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13786395 1995-06-05
JP7137863A JPH08333277A (ja) 1995-06-05 1995-06-05 ヒト血液凝固第ｘｉｉｉ因子の安定化された水性液製剤

Publications (2)

Publication Number Publication Date
DE69631930D1 true DE69631930D1 (de) 2004-04-29
DE69631930T2 DE69631930T2 (de) 2005-01-27

Family

ID=15208515

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631930T Expired - Lifetime DE69631930T2 (de) 1995-06-05 1996-06-03 Stabilisiertes wässriges flüssiges Blutgerinnungsfaktor XIII-Präparat

Country Status (9)

Country Link
US (1) US6084074A (de)
EP (1) EP0754463B1 (de)
JP (1) JPH08333277A (de)
AT (1) ATE262315T1 (de)
AU (1) AU722743B2 (de)
CA (1) CA2178144C (de)
DE (1) DE69631930T2 (de)
DK (1) DK0754463T3 (de)
ES (1) ES2213759T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4889861B2 (ja) * 1998-11-18 2012-03-07 ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー 組織接着剤のための安定化されたタンパク質調製物
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
WO2002011753A1 (fr) * 2000-08-04 2002-02-14 Chugai Seiyaku Kabushiki Kaisha Preparations proteiniques a injecter
US20040014657A1 (en) * 2001-11-05 2004-01-22 Jan Ohrstrom Use of blood coagulation factor XIII for treating haemophilia A
US20040033947A1 (en) * 2001-11-08 2004-02-19 Jan Ohrstrom Method for treating hemophilia b
PT1954308E (pt) * 2005-09-16 2011-11-03 Merial Ltd Estabilizadores para vacinas liofilizadas
HUE037932T2 (hu) * 2007-09-14 2018-09-28 Sanofi Pasteur Biologics Llc Clostridium difficile A és B toxoidjait tartalmazó gyógyászati kompozíciók
PL2268267T3 (pl) 2008-04-21 2017-12-29 Novo Nordisk Health Care Ag Kompozycja sucha transglutaminazy
JP5554244B2 (ja) * 2008-11-04 2014-07-23 あすか製薬株式会社 卵胞刺激ホルモン含有水性組成物
US10166188B2 (en) 2011-08-12 2019-01-01 Merial, Inc. Method for vacuum-assisted preservation of biologics including vaccines
EP3770254A4 (de) * 2018-03-23 2021-12-29 Ajinomoto Co., Inc. Flüssigpräparat mit transglutaminase
CN111500563B (zh) * 2020-05-08 2023-10-13 华兰生物工程重庆有限公司 一种从人血浆中纯化人凝血因子ⅶ的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
US5204447A (en) * 1988-11-14 1993-04-20 Zymogenetics, Inc. Purification of factor xiii
NZ246865A (en) * 1992-01-22 1996-10-28 Novo Nordisk As Activated factor xiii (plasma transglutaminase) and its use in food products and compositions
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
CA2178144A1 (en) 1996-12-06
ATE262315T1 (de) 2004-04-15
AU722743B2 (en) 2000-08-10
US6084074A (en) 2000-07-04
CA2178144C (en) 2008-06-03
EP0754463B1 (de) 2004-03-24
JPH08333277A (ja) 1996-12-17
ES2213759T3 (es) 2004-09-01
EP0754463A3 (de) 1999-02-03
DE69631930T2 (de) 2005-01-27
AU5472896A (en) 1996-12-19
DK0754463T3 (da) 2004-06-28
EP0754463A2 (de) 1997-01-22

Similar Documents

Publication Publication Date Title
DE69631930D1 (de) Stabilisiertes wässriges flüssiges Blutgerinnungsfaktor XIII-Präparat
NO993709L (no) Stabilisert blanding omfattende fibrinogen
DE59300238D1 (de) Gekoppelte Steuerung von Betriebsparametern eines Inkubators.
BR9006835A (pt) Agentes de controle biologico aperfeicoado de insetos,e metodos de uso
DE69636953D1 (de) Lyophilisierte hgf-zubereitungen
ATE185488T1 (de) Virussichere blutgerinnungsfaktor xiii- präparation
WO1994002611A3 (en) Recombinant human erythropoietin with altered biological activity
DE68908913D1 (de) Faktor XIII zur Vorbeugung von intraventrikulären Blutungen.
ATE322906T1 (de) Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten
ATE271125T1 (de) Neuartige tyrosinkinase
DE69227607D1 (de) Arzneimittel auf Basis von Hyaluronsäure
ATE149354T1 (de) Pharmazeutische zusammensetzung von stabilisiertem (leu 13>-motilin-hse
DK312889A (da) Vaeske til konditionering af tand- eller knoglesubstanser, deres fremstilling og anvendelse
CA2025315A1 (en) Protein-containing aqueous solutions
CY1106882T1 (el) Τροποποιηση βητακυτταρουλινης
ATE108326T1 (de) Wässerige desmopressin-cmc enthaltende arzneizubereitung.
DE69535224D1 (de) Vorrichtung und gel zur säurepufferung
ATE100493T1 (de) Proteine mit glutathion-s-transferase-aktivitaet, dna-sequenzen, antikoerper, poxviren und arzneimittel zur praevention von schistosomiasis.
UA29803A (uk) Спосіб визначення індивідуальної медикаментозної чутливості

Legal Events

Date Code Title Description
8364 No opposition during term of opposition